Ayahuasca, a psychotropic plant beverage used in traditional and modern religious ceremonies, was tested for developmental toxicity in pregnant Wistar rats. Rats received three doses—equivalent to the typical human dose, five times that, and ten times that—during gestation days 6–20. The highest dose caused maternal toxicity, including reduced weight gain and food intake. All treatment groups showed visceral fetal abnormalities; intermediate and high doses also produced skeletal findings. Fetuses from the highest dose group had lower body weight. The results indicate a dose-dependent risk of maternal and developmental toxicity from ayahuasca exposure.
Psychedelics have shown promise in treating various mental health conditions, with studies indicating a 60% reduction in symptoms for participants with depression. In a sample of 200 individuals, those receiving psychedelic therapy reported significant improvements in mood and anxiety levels compared to traditional treatments. Additionally, insights from neuroscience and neuropharmacology highlight the potential mechanisms behind these effects. In the realm of epilepsy treatment, innovative approaches are being explored, suggesting that psychedelics could play a role in enhancing therapeutic outcomes in library science and beyond.